Clinical Trials Directory

Trials / Terminated

TerminatedNCT02466659

Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia

A Clinical Trial of Observation Versus Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Indiana University School of Medicine · Academic / Other
Sex
All
Age
3 Years – 11 Years
Healthy volunteers
Not accepted

Summary

To determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old.

Detailed description

Intermittent exotropia (IXT) is the most common form of childhood-onset exotropia with an incidence of 32.1 per 100,000 in children. Before surgery, many cases of IXT are treated using non-surgical interventions, such as part-time alternate occlusion. However, the "alternating" occlusion with traditional patches is usually out of control. The investigators are uncertain about the amount of "alternating" in patching treatment. Here, the investigators introduce controlled intermittent alternating occlusion (CIAO) therapy, which is provided by a new electronic device, -liquid crystal glasses. This study is to determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old. Children with IXT will be randomized into either an observation group or a CIAO therapy group.

Conditions

Interventions

TypeNameDescription
DEVICECIAO therapy Amblyz glasses3-hour CIAO Therapy Amblyz glasses

Timeline

Start date
2015-02-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2015-06-09
Last updated
2017-11-30
Results posted
2017-11-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02466659. Inclusion in this directory is not an endorsement.